VAH631

· Novartis

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VAH631, covering 2011-11-08 to 2017-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of VAH631 in Patients With Essential Hypertension (Factorial Study) [Phase 3]